Regencell Bioscience Limited (RGC) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Regencell Bioscience Lim...

    NASDAQ: RGC · Real-Time Price · USD
    17.10
    0.95 (5.88%)
    At close: Oct 03, 2025, 3:59 PM
    16.99
    -0.64%
    After-hours: Oct 03, 2025, 07:45 PM EDT

    Regencell Bioscience Ratios and Metrics

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    PE Ratio
    		 -9.71 -51.07 -60.66 -98.57
    PEG Ratio
    		 0.36 2.47 -0.14 -1.52
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 5.08 24.92 26.38 -33.21
    P/FCF Ratio
    		 -10.42 -60.08 -74.45 -173
    P/OCF Ratio
    		 -10.44 -60.41 -85.48 -173
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.01 0.04 0.05 -0.92
    Quick Ratio
    		 41.92 19.24 28.51 0.02
    Current Ratio
    		 41.92 19.15 28.46 0.02
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -0.52 -0.49 -0.43 0.34
    Return on Assets
    		 -0.51 -0.47 -0.41 -3.96
    Return on Invested Capital
    		 -0.57 -0.5 -0.42 4.38
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist